出生前検査と新生児スクリーニングの世界市場レポート 2024年

出生前検査と新生児スクリーニングの市場規模は近年急速に拡大しています。2023年の55億2,000万米ドルから2024年には62億米ドルへと、CAGR12.4％で拡大します。過去の期間に観察された成長は、遺伝子検査の進歩、妊産婦年齢の上昇、出生前と新生児の健康に関する意識と教育の向上、医療政策と規制の変化など、さまざまな要因に起因しています。

2023年の出生前検査と新生児スクリーニング市場で最大の地域は北米でした。西欧は出生前検査と新生児スクリーニング市場で2番目に大きい地域でした。出生前検査と新生児スクリーニング市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 出生前検査と新生児スクリーニング市場の特徴

第3章 出生前検査と新生児スクリーニング市場の動向と戦略

第4章 出生前検査と新生児スクリーニング市場-マクロ経済シナリオ

第5章 世界の出生前検査と新生児スクリーニング市場規模と成長

• 世界の出生前検査と新生児スクリーニング市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の出生前検査と新生児スクリーニング市場規模実績と成長率、2018～2023年
• 世界の出生前検査と新生児スクリーニング市場規模と成長予測、2023～2028年、2033年

第6章 出生前検査と新生児スクリーニングの市場セグメンテーション

• 世界の出生前検査と新生児スクリーニング市場、診断タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 非侵襲的
• 侵襲的
• 世界の出生前検査と新生児スクリーニング市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• スクリーニング技術
• 診断技術
• 世界の出生前検査と新生児スクリーニング市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 診断センター

第7章 出生前検査と新生児スクリーニング市場の地域と国分析

• 世界の出生前検査と新生児スクリーニング市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の出生前検査と新生児スクリーニング市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋の出生前検査と新生児スクリーニング市場

第9章 中国の出生前検査と新生児スクリーニング市場

第10章 インドの出生前検査と新生児スクリーニング市場

第11章 日本の出生前検査と新生児スクリーニング市場

第12章 オーストラリアの出生前検査と新生児スクリーニング市場

第13章 インドネシアの出生前検査と新生児スクリーニング市場

第14章 韓国の出生前検査と新生児スクリーニング市場

第15章 西欧の出生前検査と新生児スクリーニング市場

第16章 英国の出生前検査と新生児スクリーニング市場

第17章 ドイツの出生前検査と新生児スクリーニング市場

第18章 フランスの出生前検査と新生児スクリーニング市場

第19章 イタリアの出生前検査と新生児スクリーニング市場

第20章 スペインの出生前検査と新生児スクリーニング市場

第21章 東欧の出生前検査と新生児スクリーニング市場

第22章 ロシアの出生前検査と新生児スクリーニング市場

第23章 北米の出生前検査と新生児スクリーニング市場

第24章 米国の出生前検査と新生児スクリーニング市場

第25章 カナダの出生前検査と新生児スクリーニング市場

第26章 南米の出生前検査と新生児スクリーニング市場

第27章 ブラジルの出生前検査と新生児スクリーニング市場

第28章 中東の出生前検査と新生児スクリーニング市場

第29章 アフリカの出生前検査と新生児スクリーニング市場

第30章 出生前検査と新生児スクリーニング市場の競合情勢と企業プロファイル

• 出生前検査と新生児スクリーニング市場の競合情勢
• 出生前検査と新生児スクリーニング市場の企業プロファイル
  • PerkinElmer Inc.
  • Laboratory Corporation of America Holdings（LabCorp）
  • Natera Inc.
  • Invitae Corporation
  • Centogene AG

第31章 世界の出生前検査と新生児スクリーニング市場の競合ベンチマーキング

第32章 世界の出生前検査と新生児スクリーニング市場の競合ダッシュボード

第33章 出生前検査と新生児スクリーニング市場における主要な合併と買収

第34章 出生前検査と新生児スクリーニング市場の将来展望と可能性分析

第35章 付録

“Prenatal Testing & Newborn Screening Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal testing & newborn screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal testing & newborn screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The prenatal testing & newborn screening market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Diagnostic Type: Non-Invasive; Invasive
• 2) By Technology: Screening Technology; Diagnostic Technology
• 3) By End user: Hospitals; Diagnostic centers
• Companies Mentioned: PerkinElmer Inc.; Laboratory Corporation of America Holdings (LabCorp); Natera Inc.; Invitae Corporation; Centogene AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Prenatal testing and newborn screening examinations serve as diagnostic procedures designed to identify potential birth defects in newborns, contributing to the assessment of the baby's overall health.

The primary diagnostic categories within prenatal testing and newborn screening encompass non-invasive and invasive methods. Invasive diagnostic testing involves procedures that penetrate the skin or body, including techniques such as blood testing, biopsies, and colonoscopies. These diagnostic methods leverage various technologies, including screening and diagnostic technology, and are applied across a range of sectors, including hospitals and diagnostic centers.

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides prenatal testing & newborn screening market statistics, including prenatal testing & newborn screening industry global market size, regional shares, competitors with prenatal testing & newborn screening market share, detailed prenatal testing & newborn screening market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing and newborn screening tests industry. This prenatal testing and newborn screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $5.52 billion in 2023 to $6.2 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed during the historical period can be attributed to various factors, including advancements in genetic testing, a rising maternal age, increased awareness and education regarding prenatal and newborn health, as well as changes in healthcare policies and regulations.

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $9.76 billion in 2028 at a compound annual growth rate (CAGR) of 12.0%. The projected growth in the forecast period can be attributed to factors such as the increasing adoption of genetic counseling, ongoing technological advancements, the expansion of point-of-care testing, and the rise of telehealth and remote monitoring. Prominent trends in this forecast period encompass the utilization of non-invasive prenatal testing (NIPT), preimplantation genetic testing (PGT), telemedicine consultations for prenatal and newborn health, maternal blood testing, as well as the focus on screening for hemoglobinopathies and sickle cell disease.

The growth of the prenatal testing and newborn screening market is significantly driven by the high prevalence of genetic diseases in infants. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Among these, Sickle Cell Anemia, which predominantly affects individuals with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry, is particularly widespread. For instance, in November 2021, the National Center for Biotechnology Information reported that genetic diseases were diagnosed in 9.4% of pediatric patients, with 44.7% of these cases occurring in critically ill newborns. This heightened prevalence of genetic diseases in infants has driven the demand for prenatal testing and newborn screening.

The prenatal testing and newborn screening market is poised for growth due to an increase in birth rates. Prenatal testing assesses the health of fetuses before birth, while newborn screening detects specific medical conditions shortly after birth, enabling early intervention when necessary. For example, in May 2022, the Centers for Disease Control and Prevention reported a 1% increase in births in 2021, totaling 3,659,289 births. The general fertility rate also rose to 56.6 births per 1,000 women aged 15-44, reflecting a 1% increase from 2020. Therefore, the rising birth rate is a key driver of the prenatal testing and newborn screening market.

The growth of the prenatal testing and newborn screening market may face challenges in developing countries with relatively limited healthcare access compared to developed nations. For instance, in May 2021, the American Hospital Association warned of a looming shortage of approximately 124,000 physicians in the United States by 2033, along with a need to recruit at least 200,000 nurses annually to meet growing demand and replace retiring nurses. In many developing nations, inadequate access to healthcare services, a shortage of hospitals and healthcare professionals, and low disposable income levels are factors that hinder market growth. This limited access to healthcare services adversely impacts the expansion of the prenatal testing and newborn screening market in such regions.

The adoption of machine learning and artificial intelligence is gradually gaining traction in the prenatal testing and newborn screening market. Artificial intelligence (AI) and machine learning aid companies in the market in conducting comprehensive data analysis, providing insights about various diseases, and delivering more precise evaluations of tissue samples. For example, in September 2021, Sema4 introduced Sema4 Elements, a suite of genetic solutions that leverage artificial intelligence and information-driven digital tools for both patients and healthcare providers. These tools aim to support comprehensive healthcare management for expectant mothers and infants within the realms of reproductive and generational health.

Major companies operating in the prenatal testing and newborn screening market are actively forming strategic partnerships. These collaborations aim to bolster research, innovation, and market access, thereby enhancing the quality of healthcare services for expectant mothers and newborns. For instance, in December 2021, OZ Systems, a health technology company, partnered with PerkinElmer Inc., a provider of genetic testing, newborn and prenatal screening, to improve newborn testing through the development of cloud-based information management systems. This strategic partnership seeks to proactively identify and diagnose health conditions in newborns to prevent disabilities and save lives.

In January 2022, Exact Sciences Corp., a molecular diagnostics company, completed the acquisition of Prevention Genetics for $190 million. This acquisition enhances Exact Sciences' advanced cancer diagnostics portfolio and allows the company to enter the hereditary cancer testing (HCT) market. Prevention Genetics, a company specializing in clinical DNA (genetic) tests for prenatal testing and newborn screening, complements Exact Sciences' capabilities and expands its market presence.

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal testing & newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Prenatal Testing and Newborn Screening Market Characteristics

3. Prenatal Testing and Newborn Screening Market Trends And Strategies

4. Prenatal Testing and Newborn Screening Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Prenatal Testing and Newborn Screening Market Size and Growth

• 5.1. Global Prenatal Testing and Newborn Screening Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Prenatal Testing and Newborn Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Prenatal Testing and Newborn Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal Testing and Newborn Screening Market Segmentation

• 6.1. Global Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Non-Invasive
• Invasive
• 6.2. Global Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Screening Technology
• Diagnostic Technology
• 6.3. Global Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers

7. Prenatal Testing and Newborn Screening Market Regional And Country Analysis

• 7.1. Global Prenatal Testing and Newborn Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Prenatal Testing and Newborn Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal Testing and Newborn Screening Market

• 8.1. Asia-Pacific Prenatal Testing and Newborn Screening Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal Testing and Newborn Screening Market

• 9.1. China Prenatal Testing and Newborn Screening Market Overview
• 9.2. China Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal Testing and Newborn Screening Market

• 10.1. India Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal Testing and Newborn Screening Market

• 11.1. Japan Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. Japan Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal Testing and Newborn Screening Market

• 12.1. Australia Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal Testing and Newborn Screening Market

• 13.1. Indonesia Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal Testing and Newborn Screening Market

• 14.1. South Korea Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. South Korea Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal Testing and Newborn Screening Market

• 15.1. Western Europe Prenatal Testing and Newborn Screening Market Overview
• 15.2. Western Europe Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal Testing and Newborn Screening Market

• 16.1. UK Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal Testing and Newborn Screening Market

• 17.1. Germany Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal Testing and Newborn Screening Market

• 18.5. France Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal Testing and Newborn Screening Market

• 19.9. Italy Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal Testing and Newborn Screening Market

• 20.13. Spain Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal Testing and Newborn Screening Market

• 21.1. Eastern Europe Prenatal Testing and Newborn Screening Market Overview
• 21.2. Eastern Europe Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal Testing and Newborn Screening Market

• 22.1. Russia Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal Testing and Newborn Screening Market

• 23.1. North America Prenatal Testing and Newborn Screening Market Overview
• 23.2. North America Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal Testing and Newborn Screening Market

• 24.1. USA Prenatal Testing and Newborn Screening Market Overview
• 24.2. USA Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal Testing and Newborn Screening Market

• 25.1. Canada Prenatal Testing and Newborn Screening Market Overview
• 25.2. Canada Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal Testing and Newborn Screening Market

• 26.1. South America Prenatal Testing and Newborn Screening Market Overview
• 26.2. South America Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal Testing and Newborn Screening Market

• 27.1. Brazil Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal Testing and Newborn Screening Market

• 28.1. Middle East Prenatal Testing and Newborn Screening Market Overview
• 28.2. Middle East Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal Testing and Newborn Screening Market

• 29.1. Africa Prenatal Testing and Newborn Screening Market Overview
• 29.2. Africa Prenatal Testing and Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Prenatal Testing and Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Prenatal Testing and Newborn Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal Testing and Newborn Screening Market Competitive Landscape And Company Profiles

• 30.1. Prenatal Testing and Newborn Screening Market Competitive Landscape
• 30.2. Prenatal Testing and Newborn Screening Market Company Profiles
  • 30.2.1. PerkinElmer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Laboratory Corporation of America Holdings (LabCorp)
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Natera Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Invitae Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Centogene AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Prenatal Testing and Newborn Screening Market Competitive Benchmarking

32. Global Prenatal Testing and Newborn Screening Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Prenatal Testing and Newborn Screening Market

34. Prenatal Testing and Newborn Screening Market Future Outlook and Potential Analysis

• 34.1 Prenatal Testing and Newborn Screening Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Prenatal Testing and Newborn Screening Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Prenatal Testing and Newborn Screening Market In 2028 - Growth Strategies
• 34.3.1 Market Trend Based Strategies
• 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer